This contradicts with the role of PADI2 shown in previously reported other cancer types and our results that both Padi2 knockdown and CRISPR/Cas9-mediated Padi2 knockout significantly inhibit the proliferation of osteoblasts (Fig. 2B and Supplementary Figure S5B). Here, PADI2 is linked to cancer.